Concepedia

Alan Xiangdong Wang

AX

5

Publications

265

Citations

5

H-Index

2014

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Alan Xiangdong Wang is an author at Bristol-Myers Squibb (United States) specializing in viral hepatitis, drug resistance, and drug discovery.

Top concepts

Publications per year

2014–2023

5

Publications

5

The Discovery of Asunaprevir (BMS-650032), An Orally Efficacious NS3 Protease Inhibitor for the Treatment of Hepatitis C Virus Infection

Paul M. Scola, Li‐Qiang Sun, Alan Xiangdong Wang et al. · Journal of Medicinal Chemistry · 2014 · 109 citations

Discovery and Early Clinical Evaluation of BMS-605339, a Potent and Orally Efficacious Tripeptidic Acylsulfonamide NS3 Protease Inhibitor for the Treatment of Hepatitis C Virus Infection

Paul M. Scola, Alan Xiangdong Wang, Andrew C. Good et al. · Journal of Medicinal Chemistry · 2014 · 66 citations · Full text

Potent Inhibitors of Hepatitis C Virus NS3 Protease: Employment of a Difluoromethyl Group as a Hydrogen-Bond Donor

Barbara Zheng, Stanley V. D’Andrea, Li‐Qiang Sun et al. · ACS Medicinal Chemistry Letters · 2018 · 38 citations · Full text

Discovery of a Potent Acyclic, Tripeptidic, Acyl Sulfonamide Inhibitor of Hepatitis C Virus NS3 Protease as a Back-up to Asunaprevir with the Potential for Once-Daily Dosing

Li‐Qiang Sun, Eric Mull, Barbara Zheng et al. · Journal of Medicinal Chemistry · 2016 · 30 citations · Full text

, , +20

Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold

Eric P. Gillis, Kyle Parcella, Michael Bowsher et al. · Journal of Medicinal Chemistry · 2023 · 22 citations

Rows per page

1–5 of 5